TeloNostiX is an innovative in vitro diagnostics company specializing in high-resolution telomere length analysis for both clinical and research applications. By utilizing their advanced platform technologies, TeloNostiX offers valuable insights into the prognosis and treatment response of individual cancer patients, as well as the development of risk-adapted clinical trials. At the core of TeloNostiX's services is their Single Telomere Length Analysis (STELA), which provides the highest resolution approach to determine telomere length.

This cutting-edge technology enables precise measurements for bespoke research applications. Additionally, TeloNostiX offers High-Throughput STELA, a powerful tool for accurate telomere length determination in large-scale analysis and clinical settings. By providing high-resolution telomere analysis, TeloNostiX plays a crucial role in the advancement of precision medicine.

Their services are not limited to cancer research, as they also offer solutions for cellular therapeutics and telomere-related disorders. For more information about TeloNostiX's technologies and services, visit their website or contact them directly at info@telonostix. com